Azelon Pharmaceuticals
Latest round
- Series A
Last raised
- Mar 2012
Total raised
- $5.3M
Investors
- 3
About Azelon Pharmaceuticals
Azelon Pharmaceuticals specializes in developing innovative pharmaceutical solutions aimed at improving patient outcomes.Azelon Pharmaceuticals is a firm founded in 2000 in the United States, focused on pharmaceutical innovations. The company has operated under a consistent business strategy, concentrating on the development of new drug formulations. The founder's background includes previous ventures in the pharmaceutical industry, although specific details are not mentioned.Azelon Pharmaceuticals is dedicated to the development of pharmaceutical products that cater to diverse medical needs. Their offerings include various medications designed to treat specific health conditions, focusing on enhancing efficacy and patient compliance.Azelon Pharmaceuticals generates revenue through the sale of its pharmaceutical products, utilizing a direct sales model to healthcare providers and institutions. The company engages in structured pricing for its medicines, allowing them to meet the varying budgetary requirements of healthcare systems.Azelon Pharmaceuticals has announced plans to expand its product line with several new drug formulations expected to be launched in the coming years. The company is targeting entry into new geographic markets, specifically Europe and Asia, by the end of 2025.
Who invested in Azelon Pharmaceuticals
3 investors across 2 rounds
See all investors in Azelon Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Azelon Pharmaceuticals
Who invested in Azelon Pharmaceuticals?
Azelon Pharmaceuticals has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Azelon Pharmaceuticals raised?
Azelon Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Azelon Pharmaceuticals last raise money?
Azelon Pharmaceuticals's most recent round on record is a Series A, in Mar 2012.
What does Azelon Pharmaceuticals do?
Azelon Pharmaceuticals specializes in developing innovative pharmaceutical solutions aimed at improving patient outcomes.
Where is Azelon Pharmaceuticals headquartered?
Azelon Pharmaceuticals is headquartered in US.
Which VCs invest in companies like Azelon Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Azelon Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Azelon Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.